CD70 and renal cell carcinoma: Physiologically, the appearance of CD70 is largely restricted to transient expression on antigen-activated T and B cells, natural killer cells and mature dendritic cells (23), but aberrant CD70 expression has been reported in many hematological cancers and several solid tumors (22, 26), including RCC where it is associated with metastasis and poor survival (23).